Characteristics Differ for Melanomas in Children, Teens, Young Adults
By Elana Gotkine HealthDay Reporter
TUESDAY, Nov. 26, 2024 -- Tumor characteristics differ significantly among pediatric and adolescent and young adult (AYA) patients with melanoma, with decreasing incidence rates seen among young patients with cutaneous melanoma, according to a study published online Nov. 15 in the Journal of the American Academy of Dermatology.
Bianca E. Ituarte, from the University of Nebraska Medical Center in Omaha, and colleagues examined the incidence trends and melanoma presentations based on age, sex, race, and ethnicity using a large cohort of diagnoses from 1997 to 2020 in a retrospective cohort study completed using the National Childhood Cancer Registry for pediatric and AYA patients.
The researchers found that for pediatric and AYA patients, the incidence rates were 1.74 and 62.05 per 1 million person-years, respectively. Overall, 62.3 percent of the cohort was female. Non-Hispanic White patients accounted for 87.5 percent of all diagnoses, with the incidence rates of melanoma significantly higher compared with all other racial and ethnic groups in pediatric and AYA patients. The most common of the specified histologic subtypes was superficial spreading. In pediatric patients, the most common location was the lower extremity compared with the trunk in AYA. In both pediatric and AYA groups, there were significant differences in the distributions of primary tumor location by sex and by race and ethnicity.
"While a melanoma diagnosis in this age group is rare, our data provide incidence rates by age, gender, race and ethnicity, and clinical presentation patterns that can help the clinician understand individuals who may be at risk," the authors write.
One author disclosed ties to Castle Biosciences.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
Circulating Tumor DNA Can ID Outcomes for Patients With Melanoma
WEDNESDAY, April 16, 2025 -- Droplet digital polymerase chain reaction (PCR) measurements of cell-free, circulating tumor DNA (ctDNA) can identify patients with melanoma and a...
Common Photosensitizing Drugs Increase Skin Cancer Risk
TUESDAY, April 1, 2025 -- Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in Photodermatology...
Adding 3D Total Body Photography to Usual Care Increases Rate of Skin Excisions
WEDNESDAY, March 26, 2025 -- The addition of three-dimensional (3D) total-body photography (TBP) and sequential digital dermoscopy imaging (SDDI) via teledermatology to usual care...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.